There are 2789 resources available
1010P - Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008
Presenter: Thomas Eigentler
Session: ePoster Display
1011P - FORTITUDE phase I study of NG-350A, a novel tumour-selective adenoviral vector expressing an anti-CD40 agonist antibody: Monotherapy dose escalation results
Presenter: Aung Naing
Session: ePoster Display
926TiP - Phase II trial of enoblituzumab plus retifanlimab or tebotelimab in first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M SCCHN)
Presenter: Grzegorz Obara
Session: ePoster Display
928TiP - Induction versus adjuvant gemcitabine/cisplatin in locally advanced non-metastatic nasopharyngeal carcinoma: A randomised phase III trial
Presenter: Shereen Masoud
Session: ePoster Display
929TiP - HERODOTUS: Head and neck cancers international COVID-19 collaboration: An international registry on head and neck cancer with COVID-19
Presenter: Amanda Psyrri
Session: ePoster Display
930TiP - innovaTV 207: New dosing cohort in the open label phase II study of tisotumab vedotin in solid tumors
Presenter: David Hong
Session: ePoster Display
931TiP - Malnutrition based on the GLIM criteria and the response to concurrent chemoradiotherapy in patients with squamous cell carcinoma of the head and neck
Presenter: Maria João de Sousa
Session: ePoster Display